Evidence map›Paper›PMID 38050662›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Tau-neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum.

Xueying Lyu, Michael Tran Duong, Long Xie, Robin de Flores, Hayley Richardson, Gyujoon Hwang, Laura E M Wisse, Michael DiCalogero, Corey T McMillan, John L Robinson and 10 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI).Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  19. Tau-neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Xueying LyuDepartments of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Michael Tran DuongDepartments of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Long XieDepartments of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Robin de FloresUniversité de Caen Normandie, INSERM UMRS U1237, Caen, France.
Hayley RichardsonDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Gyujoon HwangDepartments of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Laura E M WisseDepartment of Clinical Sciences Lund, Lund University, Lund, Sweden.
Michael DiCalogeroDepartments of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Corey T McMillanDepartments of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
John L RobinsonDepartments of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sharon X XieDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Edward B LeeDepartments of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
David J IrwinDepartments of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Bradford C DickersonMassachusetts General Hospital, Boston, Massachusetts, USA.
Christos DavatzikosDepartments of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ilya M NasrallahDepartments of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Paul A YushkevichDepartments of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
David A WolkDepartments of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sandhitsu R DasDepartments of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Alzheimer's Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Corey T McMillan · 2021 to 2026
$24.8M
Understanding Environmental Contributions to Heterogeneity in bvFTD.P01AG066597 · NIA · UNIVERSITY OF PENNSYLVANIA · PI David John Irwin, Corey T McMillan · 2020 to 2026
$18.8M
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"U19AG062418 · NIA · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2019 to 2023
$18.1M
Project IV: In Vivo Dissection of Genetic Modifiers on Different Stages of SynucleinopathyP01AG084497 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DANIEL WEINTRAUB · 2024 to 2026
$15.2M
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology AssociationsR01AG056014 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Paul A. Yushkevich · 2017 to 2026
$4.5M
Characterization of relationship between tau pathology and neurodegeneration in Alzheimer's disease using multimodal imagingR01AG072796 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Sandhitsu Das, DAVID A WOLK · 2022 to 2026
$4.0M
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's diseaseRF1AG069474 · NIA · UNIVERSITY OF PENNSYLVANIA · PI WOLK, DAVID A, YUSHKEVICH, PAUL A. · 2021 to 2021
$2.1M
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology AssociationsRF1AG056014 · NIA · UNIVERSITY OF PENNSYLVANIA · PI YUSHKEVICH, PAUL A. · 2023 to 2023
$2.1M
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's diseaseR01AG069474 · NIA · UNIVERSITY OF PENNSYLVANIA · PI WOLK, DAVID A, YUSHKEVICH, PAUL A. · 2024 to 2025
$1.4M
NIA NIH HHS P01 AG066597NIA NIH HHS P01AG066597NIA NIH HHS P01 AG084497NIA NIH HHS P30 AG072979NIA NIH HHS P30AG072979NIA NIH HHS R01 AG056014NIA NIH HHS R01 AG069474NIA NIH HHS R01 AG072796NIA NIH HHS RF1 AG056014NIA NIH HHS RF1 AG069474NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG062418NIA NIH HHS U19AG062418NIBIB NIH HHSNIH HHS U01 AG024904
6 · The paper itself

Abstract

introductionVariability in relationship of tau-based neurofibrillary tangles (T) and neurodegeneration (N) in Alzheimer's disease (AD) arises from non-specific nature of N, modulated by non-AD co-pathologies, age-related changes, and resilience factors.

methodsWe used regional T-N residual patterns to partition 184 patients within the Alzheimer's continuum into data-driven groups. These were compared with groups from 159 non-AD (amyloid "negative") patients partitioned using cortical thickness, and groups in 98 patients with ante mortem MRI and post mortem tissue for measuring N and T, respectively. We applied the initial T-N residual model to classify 71 patients in an independent cohort into predefined groups.

resultsAD groups displayed spatial T-N mismatch patterns resembling neurodegeneration patterns in non-AD groups, similarly associated with non-AD factors and diverging cognitive outcomes. In the autopsy cohort, limbic T-N mismatch correlated with TDP-43 co-pathology. DISCUSSION: T-N mismatch may provide a personalized approach for determining non-AD factors associated with resilience/vulnerability in AD.

Indexed as

Alzheimer DiseaseResilience, PsychologicalAmyloid beta-PeptidesHumansMagnetic Resonance ImagingNeurofibrillary Tanglestau ProteinsAmyloid beta-Peptidestau ProteinsagingAlzheimer's diseaseco-pathologiesmulti-modality imagingneurodegenerationpost mortemtau

Identifiers

PMID38050662
PMCPMC10984442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.